Preliminary Quality Criteria of Citrate-Protected Gold Nanoparticles for Medicinal Applications
Preliminary Quality Criteria of Citrate-Protected Gold Nanoparticles for Medicinal Applications
复制标题
DOI:
10.1021/acsanm.8b00192
复制
发表时间:
2018-04
期刊:
影响因子:
--
通讯作者:
Jia-Jia Shen-Jia;Pingbo Zhang;Feng Zheng;Huan Chen;Wei Chen;Ya Ding;X. Xia
中科院分区:
文献类型:
--
作者:
Jia-Jia Shen-Jia;Pingbo Zhang;Feng Zheng;Huan Chen;Wei Chen;Ya Ding;X. Xia
Gold nanoparticles (GNPs) are one of the most widely studied and utilized materials in nanomedicine, but there is no business or national quality standard for their medicinal applications. This has become the bottleneck in the translation of clinical applications of gold-based nanomaterials. To solve this issue, the most frequently used citrate-reduced GNPs were selected as demonstration in this study to conduct quality standard research. The different molar ratios of chloroauric acid to trisodium citrate in preparation were changed, from 1:1 to 1:5, to adjust the particle size and main ingredients in gold colloids. The compositions of reduced Au0 and residual Au3+ were determined by X-ray photoelectron spectroscopy (XPS), inductively coupled plasma–atomic emission spectroscopy (ICP-AES), and photodynamic catalysis, while the residual citrate and its oxidation products in supernatants were detected by nuclear magnetic resonance (1H NMR) spectroscopy and nonaqueous titration. Cell viability of human normal...